Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating the combination of rituximab with chemotherapy for HIV-associated non-Hodgkin lymphoma, including AIDS-related DLBCL, immunob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Diffuse Large B-cell Lymphoma
• Aids-related Immunoblastic Lymphoma
• Aids-related Peripheral Systemic Lymphoma
• Aids-related Small Noncleaved Cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2011-06-22